Notice Regarding the Scheduled Commencement of a Tender Offer for Share Certificates, etc. of Matsuya R&D Co., Ltd.
Notice Regarding the Scheduled Commencement of a Tender Offer for Share Certificates, etc. of Matsuya R&D Co., Ltd.
Kyoto, Japan (December, 16th , 2025) - OMRON Healthcare Co., Ltd. has announced its intention to acquire all shares of MATSUYA R&D Co., Ltd. (Head Office: Ōno City, Fukui; Representative Director and CEO: Hidetaka Goto, hereinafter "Matsuya R&D") through a tender offer for shares and other securities based on the Financial Instruments and Exchange Act (Act No. 25 of 1948, including subsequent amendments).
Background
Our vision is “Going for ZERO, Preventive Care for the Health of Society”. To achieve this vision, we globally develop and provide medical devices and services that contribute to the early detection, prevention of severe progression, and recurrence prevention of cardiovascular diseases. Our cardiovascular business is strengthened by the technological expertise cultivated since the launch of our first blood pressure monitor in 1973, and the insights gained through collaboration with numerous physicians and academic societies. Today, we provide products and services to more than 130 countries and regions worldwide.
Matsuya R&D develops, manufactures, and sells automated sewing machines, as well as various sewn products produced using its proprietary automated sewing technology. The company’s strength lies in production lines equipped with its high-performance sewing machines, ensuring a stable supply of high-quality sewn products. Among these are the cuffs* used in our blood pressure monitors.
*1 A specialized air bladder wrapped around the arm or wrist during blood pressure measurement to apply and release pressure.
Purpose of Making a Wholly Owned Subsidiary
By making Matsuya R&D a wholly owned subsidiary, we believe we can achieve greater synergies by sharing management resources and jointly advancing projects. This will enable us to enhance the quality of blood pressure cuffs—a critical factor in the accuracy and quality of blood pressure monitors—strengthen our competitiveness in the intensifying global blood pressure monitor market, and accelerate the development of new products.
We determined that making it a wholly owned subsidiary and advancing measures for corporate growth is the optimal approach to flexibly and proactively promote initiatives that will enhance the competitiveness and profitability of both companies over the medium to long term.
About OMRON Healthcare
Committed to advancing health and empowering people worldwide to live life to the fullest, OMRON Healthcare is a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment.
Aiming to realize its vision, “Going for ZERO, Preventive Care for the Health of Society,” the company develops products for cardiovascular condition management, respiratory care, and pain therapy. Building on this, it has introduced a new digital health ecosystem that bridges patients and healthcare professionals, helping to reduce cerebro-cardiovascular events, the worsening of respiratory diseases, and limitations caused by chronic pain.
With over 400 million units sold globally, OMRON provides the world's most recommended blood pressure monitors by healthcare professionals. Throughout its history, OMRON Healthcare has striven to improve lives and contribute to a better society by developing innovations that help people prevent, treat, and manage their medical conditions, providing products and services in over 130 countries.